University Hospital, Basel, Switzerland: Atrial Fibrillation trials

The registry lists 18 Atrial Fibrillation studies with University Hospital, Basel, Switzerland as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 2 1Phase 3 1No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Redo-Pulmonary Vein Isolation With Versus Without Posterior Wall Ablation - The REDO-PIFPAF-PFA StudyNot yet recruitingNCT07745543Not applicable
• Feasibility Study: Continuous ECG and Blood Pressure Monitoring With the M2VS Sensor SystemNot yet recruitingNCT07694570
• Colchicine After Electrocardioversion for Atrial FibrillationRecruitingNCT05890664Phase 3
• The Basel CardioInsightTM - 3D Mapping StudyRecruitingNCT04964765
• Swiss Atrial Fibrillation Pulmonary Vein Isolation RegistryRecruitingNCT03718364
• Long-term Outcome Following Concomitant Surgical Ablation for Atrial Fibrillation at University Hospital Basel: A Retrospective StudyCompletedNCT05542017
• Health Consequences of the Burden of Atrial FibrillationCompletedNCT05389228
• Accuracy of Cardiac Wearables Devices to Detect Atrial FibrillationCompletedNCT04809922
• Determine AF Burden With PPG Trial - Detection and Quantification of Episodes of Atrial FibrillationCompletedNCT04563572Not applicable
• RedStroke - Reducing Europe's Stroke IncidenceCompletedNCT04108884Not applicable
• Characterization of Left Atrial Substrate by Comparison of Bipolar Voltage Maps With Standard Focal 4.5 mm Tip Electrode, 1 mm Ring Electrode, and Microelectrode Catheters Using InTEllaMap Orion and IntellaNav MIFI OCompletedNCT04095559
• New Oral Anticoagulants (NOAC) in Stroke PatientsCompletedNCT03826927
• Development of a Questionnaire to Assess Patient Knowledge About Non-vitamin K Anticoagulants (NOAC)CompletedNCT03124654
• SmartWATCHes for Detection of Atrial FibrillationCompletedNCT02956343
• Enhanced Diagnostics for Early Detection of Atrial Fibrillation - Prospective ValidationCompletedNCT02949180
• Enhanced Diagnostics for Early Detection of Atrial FibrillationCompletedNCT02270112
• Swiss Atrial Fibrillation Cohort StudyActive, not recruitingNCT02105844
• Canakinumab for the Prevention of Recurrences After Electrical Cardioversion: CONVERT-AFTerminatedNCT01805960Phase 2